The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health 250 Washington Street, Boston, MA 02108-4619 Massachusetts Department of Public Health Minutes of the Drug Formulary Commission Meeting of Thursday, August 17, 2017 Henry I. Bowditch Public Health Council Room, 2nd Floor 250 Washington Street Boston, MA 02114 Date of Meeting: Thursday, August 17, 2017 Beginning Time: 9:06 AM Ending Time: 10:04 AM Advisory Council Members Present: The following (11) appointed members of the Drug Formulary Commission attended on December 15, 2016, establishing the required simple majority quorum (9) pursuant to Massachusetts Open Meeting Law (OML): DPH Bureau of Health Care Safety and Quality Director Eric Sheehan (Chair); Dr. Douglas Brandoff; Cheryl Campbell; Dr. Daniel Carr; Dr. Joanne Doyle-Petrongolo; Stephen Feldman, Dr. Kenneth Freedman; Dr. Paul Jeffrey; Tracey McMillan; Cindy Steinberg; and Dr. Theoharis Theoharides. 1. Welcome and Introductions Eric Sheehan called the meeting to order at 9:06AM Mr. Sheehan thanked everyone for here today, and reminded everyone that the meeting was being recorded. He then asked if anyone was recording, receiving no affirmative response. Mr. Sheehan began the meeting by recapping the May 18th meeting. At this meeting, the Commission approved Morphabond ER and Arymo ER as IAD drug products, and five abuse deterrent Morphine ER drug products as substitutes for both. Commission staff also presented the timeline for continued review of the proposed amendments to 105 CMR 720, including the first draft formulary. Next, Mr. Sheehan called for approval of the minutes from the May 18, 2017 meeting.
The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health 250 Washington Street, Boston, MA 02108-4619 Massachusetts Department of Public Health Minutes of the Drug Formulary Commission Meeting of Thursday, August 17, 2017 Henry I. Bowditch Public Health Council Room, 2nd Floor 250 Washington Street Boston, MA 02114 Date of Meeting: Thursday, August 17, 2017 Beginning Time: 9:06 AM Ending Time: 10:04 AM Advisory Council Members Present: The following (11) appointed members of the Drug Formulary Commission attended on December 15, 2016, establishing the required simple majority quorum (9) pursuant to Massachusetts Open Meeting Law (OML): DPH Bureau of Health Care Safety and Quality Director Eric Sheehan (Chair); Dr. Douglas Brandoff; Cheryl Campbell; Dr. Daniel Carr; Dr. Joanne Doyle-Petrongolo; Stephen Feldman, Dr. Kenneth Freedman; Dr. Paul Jeffrey; Tracey McMillan; Cindy Steinberg; and Dr. Theoharis Theoharides. 1. Welcome and Introductions Eric Sheehan called the meeting to order at 9:06AM Mr. Sheehan thanked everyone for here today, and reminded everyone that the meeting was being recorded. He then asked if anyone was recording, receiving no affirmative response. Mr. Sheehan began the meeting by recapping the May 18th meeting. At this meeting, the Commission approved Morphabond ER and Arymo ER as IAD drug products, and five deterrent Morphine ER drug products as substitutes for both. Commission staff also presented the timeline for continued review of the proposed amendments to 105 CMR 720, including the first draft formulary. Next, Mr. Sheehan called for approval of the minutes from the May 18, 2017 meeting. abuse
dfc-august-17-approved-minutes-10-10-17.docx